BFP420 Infineon Technologies, BFP420 Datasheet - Page 10

• Manufacturer Part Number: BFP420
• Description: RF TRANSISTOR, NPN, 4.5V, 25GHZ, SOT-343
• Manufacturer: Infineon Technologies

Specifications of BFP420

• Transistor Polarity: NPN
• Collector Emitter Voltage V(br)ceo: 4.5V
• Transition Frequency Typ Ft: 25GHz
• Power Dissipation Pd: 160mW
• Dc Collector Current: 35mA
• Dc Current Gain Hfe: 95
• Packages: SOT343
• Vceo (max): 4.5 V
• Ic(max): 35.0 mA
• Nfmin (typ): 1.1 dB
• Gmax (typ): 21.0 dB
• Oip3: 22.0 dBm
• Lead Free Status / RoHS Status: Lead free / RoHS Compliant

BFP420
Edition 2006-02-01
Published by
Infineon Technologies AG
81726 München, Germany
© Infineon Technologies AG 2006.
All Rights Reserved.
Attention please!
The information given in this dokument shall in no event be regarded as a guarantee
of conditions or characteristics (“Beschaffenheitsgarantie”). With respect to any
examples or hints given herein, any typical values stated herein and/or any information
regarding the application of the device, Infineon Technologies hereby disclaims any
and all warranties and liabilities of any kind, including without limitation warranties of
non-infringement of intellectual property rights of any third party.
Information
For further information on technology, delivery terms and conditions and prices
please contact your nearest Infineon Technologies Office (
www.infineon.com
).
Warnings
Due to technical requirements components may contain dangerous substances.
For information on the types in question please contact your nearest
Infineon Technologies Office.
Infineon Technologies Components may only be used in life-support devices or
systems with the express written approval of Infineon Technologies, if a failure of
such components can reasonably be expected to cause the failure of that
life-support device or system, or to affect the safety or effectiveness of that
device or system.
Life support devices or systems are intended to be implanted in the human body,
or to support and/or maintain and sustain and/or protect human life. If they fail,
it is reasonable to assume that the health of the user or other persons
may be endangered.
2006-03-24
10